key: cord-0719540-nkq6ueas
authors: Yamada, Takayuki; Mikami, Takahisa; Chopra, Nitin; Miyashita, Hirotaka; Chernyavsky, Svetlana; Miyashita, Satoshi
title: Is there a racial disparity in coronavirus disease 2019 patients with chronic kidney disease? An experience in New York City
date: 2021-07-06
journal: Int J Clin Pract
DOI: 10.1111/ijcp.14261
sha: 94844f7588810631820c00a9ea05e60ada18b257
doc_id: 719540
cord_uid: nkq6ueas

nan

Dear Editor, Since December 2019, coronavirus 2019 (COVID-19) has spread worldwide. 1 Some data have suggested that the prevalence and mortality of COVID-19 are different among races, even after adjusting for comorbidities and income. 2 Since chronic kidney disease (CKD) is common, the number of COVID-19 patients with CKD will increase. However, there are scarce data about outcomes in CKD patients. We herein investigated the outcomes from COVID-19 in AAs with CKD compared to those in whites with CKD.

We analysed Mount Sinai Health System (MSHS) medical records up to 5 April 2020, using Epic SlicerDicer software, a tool to abstract deidentified aggregate-level data. We extracted data from patients who had positive for the COVID-19 reverse-transcription polymerase chain reaction (RT-PCR) test. We selected CKD pa- (Table 1) .

To the best of our knowledge, this is the first study that compared the risk of severe outcomes among races in CKD patients.

Although it has been suggested that there might be racial disparity in COVID-19, our study did not show any significant differences in outcomes, even after stratifying patients by age and comorbidities.

The racial and ethnic diversity in NYC enabled us to investigate differences in outcomes among races in the same cohort. However, our study has several limitations. First, the number of patients was relatively small. Second, we did not access individual data, which prevented us from performing multivariate analyses. Third, extracting CKD patients based on ICD-10 codes may miss patients with albuminuria. Lastly, the fact that AAs were younger might mask differences among races.

In conclusion, AAs with CKD did not have a higher risk of mortality or ICU admission than whites with CKD. This trend was consistent after stratification by age, sex, or comorbidities. TA B L E 1 Relative risks of ICU admission and death in patients with each race stratified by age and comorbidities

Preliminary estimates of the prevalence of selected underlying health conditions among patients with coronavirus disease 2019 -United States

Disparities in outcomes among COVID-19 patients in a large health care system in California